Hepaxane (Enoxaparin Sodium)

Hepaxane is indicated for several anticoagulation purposes in adult patients. It is commonly employed in the following clinical situations:

• Prevention of deep vein thrombosis (DVT) in patients undergoing orthopedic or general surgery.
• Prophylaxis of pulmonary embolism (PE) in at‑risk individuals.
• Treatment of acute DVT and PE when rapid anticoagulation is required.
• Anticoagulation support during hemodialysis procedures.
• Prevention of thromboembolic events in patients with limited mobility or other risk factors.

Side effects of Hepaxane vary in frequency and severity. Common reactions are usually mild, while serious events are less frequent but require immediate medical attention.

Common

• Minor bruising or bleeding at the injection site.
• Nosebleeds (epistaxis).
• Small amounts of blood in urine or stool.
• Mild headache.
• Elevated liver enzymes.

Serious

• Major bleeding, such as gastrointestinal or intracranial hemorrhage.
• Severe allergic reactions, including rash, itching, or swelling.
• Thrombocytopenia (low platelet count) that may lead to bleeding.
• Spinal or epidural hematoma after neuraxial procedures.

Before initiating Hepaxane therapy, several safety considerations should be reviewed. These precautions help minimize the risk of adverse events and ensure appropriate use:

• Assess renal function, as dose adjustments may be needed in patients with impaired kidneys.
• Review patient history for active bleeding, recent surgery, or trauma.
• Use cautiously in pregnant or breastfeeding women; category B indicates limited risk but requires clinical judgment.
• Monitor platelet counts regularly to detect heparin‑induced thrombocytopenia.
• Avoid concurrent use with other anticoagulants or antiplatelet agents unless specifically indicated.
• Adjust dose in elderly patients or those with low body weight.

Hepaxane can interact with several medications, potentially altering its anticoagulant effect or increasing bleeding risk. Understanding these interactions supports safe prescribing.

Avoid

• Concurrent use of other anticoagulants (e.g., warfarin, direct oral anticoagulants).
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) and aspirin at high doses.
• Thrombolytic agents such as alteplase or streptokinase.

Use with caution

• Antiplatelet drugs (e.g., clopidogrel, ticagrelor) where combined bleeding risk is a concern.
• Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents.
• Certain antibiotics (e.g., quinolones) that may affect platelet function.
• Herbal supplements like ginkgo biloba or garlic that can potentiate bleeding.